Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseMarc S. Sabatine, Terje R. Pedersen, Thomas Liu et al.|New England Journal of Medicine|2017Cited by 6k
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular DiseaseMichelle L. O’Donoghue, Marc S. Sabatine, Robert S. Rosenson et al.|New England Journal of Medicine|2022Cited by 513
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison Stopeck, Ada Braun, Karim Fizazi et al.|Supportive Care in Cancer|2015Cited by 190
Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Paul J. Kostenuik, Henry G. Bone et al.|European Journal of Cancer|2015Cited by 150